Storia in 4 fonti

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda

U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Therapeutics for $10.9B. Other gaining stocks include DFTX, HIVE, SSTK, BWIN, ICCM, ORKA, CHRN, UMC, MLTX, FRVO, and SMCI.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo1 mese fa

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda

AbbVie acquires Apogee ($10.9B); broad rally on semiconductor (SMCI +14%, ON +7.5%, CRDO +11.5%) signals risk-on capex. Signal for tech leaders: watch for capex shift toward AI infrastructure and hardware; SaaS-lean budgets may reallocate to chip vendor partnerships.

originale

Timeline cronologica

lunedì 22 giugno 2026·biopharmadive.com
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs
AbbVie’s largest deal in more than half a decade adds a group of immune disease medications — among them a Dupixent competitor — the company believes to have “mega-blockbuster”…
lunedì 22 giugno 2026·statnews.com
AbbVie to buy Apogee Therapeutics in nearly $11B deal
AbbVie is buying Apogee Therapeutics, the developer of an experimental atopic dermatitis drug, for nearly $11B, continuing a run of pharma acquisitions.

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda

Confronto fonti

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda

Timeline cronologica

AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs

AbbVie to buy Apogee Therapeutics in nearly $11B deal

Healthcare Stocks Gain in Mixed U.S. Session — Healthcare Roundup

AbbVie to buy Apogee Therapeutics in nearly $11B deal

AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs

Crude Oil Falls Over 2%; Getty Images Shares Spike Higher - AbbVie (NYSE:ABBV), Apogee Therapeutics (NASD

Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monda

Healthcare Stocks Gain in Mixed U.S. Session — Healthcare Roundup

AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst - AbbVie (NYSE:ABBV), Apogee Therapeutic